Perspectives - Page 10

Cracking the Code: Unlocking Key Opinion Leaders in the Digital Landscape

Our experts delve into the dynamic interplay between the traditional and digital realms and why fully understanding the value of both options is fundamental to identifying the right mix of opinion leaders needed to maximize reach and communicate your message with credibility, authenticity, and authority.

Whitepaper Nov 14, 2023

Demystifying Biotech Commercialization in Europe

Resource

Supporting a Pharma Company with Lifecycle Management Strategy

Case Study Nov 13, 2023

5 Key Takeaways from the 2023 BIO-Europe Congress

View Nov 9, 2023

Opportunity Assessment to Help an Early-Stage Biotech Company Select an Indication of Focus to Maximize Launch Success of an Immune-Modulating Product

Case Study Nov 6, 2023

Opportunity Assessment for Novel Therapeutic in a Rare Neuromuscular Disorder

Our client, a development stage biotech start-up, sought to explore the landscape for their novel disease-modifying therapeutic–all to shape their near-term strategy as well as to quantify the opportunity for their lead asset.

Case Study Nov 3, 2023

The Importance of Real World Evidence Strategy Planning

Podcast Nov 2, 2023

European Perspectives of the Inflation Reduction Act

View Oct 31, 2023

Aiding Investment Decisions in Neurology-Focused Clinical Research and Site Management Organizations

Case Study Oct 30, 2023

Medical Affairs Unscripted | Untapped Potential of Social Media Listening in Medical Affairs

Podcast Oct 30, 2023

Earlier or Faster? The Impact of the IRA on Oncology Drug Development

On-Demand Webinar Oct 26, 2023

Commercialization as ‘Plan A’: Innovator Biotechs Must Define and Own Their Commercial Strategy, Beginning Early

On-Demand Webinar Oct 26, 2023

Charting the Course for Biotechnology Commercialization Success: De-risking and Maximizing Regulatory, Access, and Commercial Potential in Europe

Whitepaper Oct 26, 2023

Early Interception in Cancer: How Can the Current Medical and Industry Paradigm of Managing Advanced Cancer Be Turned on Its Head?

On-Demand Webinar Oct 25, 2023

4 Takeaways from the 2023 NORD Rare Diseases and Orphan Products Breakthrough Summit

View Oct 25, 2023

Adapting a Launch Strategy for CNS Market Entry in the US for a Drug Device Combination

A European medical technology and pharmaceutical company with an approved sedative for anesthesia in Europe aimed to enter the US market. They came to Lumanity to understand the key differences between commercializing in Europe and the US, as well as understand the potential value of the US opportunity and the investment requirements, to determine how to approach organizational scale-up and level-set on revenue expectations. Discover how we helped.

Case Study Oct 23, 2023